Connect with us:

Facebook Twitter RSS

News & Updates

03 Oct 2014

Core values for a new cancer culture: six centres create Cancer Core Europe

Six cancer centres of international note have announced the creation of Cancer Core Europe: a consortium to address the cancer care/cancer research continuum challenge.

The optimal treatment of cancer remains one of the major medical challenges globally, due to the high diversity in the spectrum of mutations in individual cancer patients.

To tackle this issue, cancer programmes must be better integrated and performed at a large scale.

European cancer research is therefore in need of a transformative initiative whereby a consortium of comprehensive cancer centres of excellence will work collectively to carry out joint translational and clinical research in cancer treatment and care.

To deliver this objective, Gustave Roussy Cancer Campus Grand Paris (Villejuif – France), Cambridge Cancer Centre (Cambridge, United Kingdom), Karolinska Institutet – KI (Stockholm, Sweden), Netherlands Cancer Institute – NKI (Amsterdam, The Netherlands), Vall d’Hebron Institute of Oncology – VHIO (Barcelona, Spain) and the German Cancer Research Center – DKFZ and its National Centre for Tumour Diseases – NCT (Heidelberg, Germany) have jointly decided to create Cancer Core Europe.

As a working consortium, Cancer Core Europe will be a translational platform to build the bridge from "bench-to-bedside and bedside-to-bench" and to conduct next-generation clinical trials focused on proof-of-concept, companion predictive and resistance-monitoring biomarkers.

The creation of a virtual single “e-hospital”

The prerequisites for joint translational and clinical research programmes are very demanding.

These require a powerful translational platform that integrates all patient files using a common software platform that federates the databases from each of the centres; inter-compatible clinical molecular profiling laboratories with a robust underlying computational biology pipeline; standardised functional and molecular imaging; commonly agreed standard operating procedures for liquid and tissue biopsy procurement, storage and processing, for molecular diagnostics, “-omics”, functional genetics, immune-monitoring; a culture of data collection and storage that facilitates complete longitudinal data sets.

A critical mass of activity for the successful integration of all cancer care information, clinical research and outcome research

Cancer Core Europe is expected to support the full spectrum of research required to address the cancer research – cancer care continuum. Cancer Core Europe also constitutes a unique environment for the training of up-and-coming talents in innovative translational and clinical oncology.

Within the Cancer Core Europe consortium around 60,000 newly diagnosed cancer patients are seen, 300,000 cancer treatments are delivered and about 1,000,000 outpatient visits are performed every year.

More than 1,500 clinical trials are conducted at these six cancer centres annually.

This represents a "unique critical mass" of activity, that once successfully harmonised as one operational clinical research structure, will represent a major force in European cancer research.


To read the article in the Journal of Molecular Oncology click here.

For more on this watch the interview with Alexander Eggermont on

Source: Gustave Roussy

More publications

14 Dec 2016: Preserving fertility in girls and young women with cancer “haphazard” say experts 23 Dec 2015: 'Hematological Malignancies: from Mechanisms to Therapy' symposium - March 9/12, 2016 - Milan 02 Dec 2015: European cancer centres finally united in long-term collaborative partnerships 19 Nov 2015: SiRIC-Curie Call for translational research group leaders, Paris, France 20 Oct 2015: IARC Fellowships for Cancer Research 03 Aug 2015: Optimizing sharing of hospital biobank samples: new EurocanPlatform paper published in Science Translational Medicine 17 Jul 2015: 3rd EurocanPlatform Summer School in Translational Cancer Research: Portugal, 12 – 16 October 2015 17 Jul 2015: NCT Heidelberg School of Oncology Fellowship Program in Translational Cancer Research - Call for applications 01 Jul 2015: EurocanPlatform project engages directly with patient groups at ECPC AGM 19 Jun 2015: EurocanPlatform Translational Research Course 12th - 16th October - Save the Date! 13 May 2015: Catch up on all the latest from the EurocanPlatform project in the May 2015 Newsletter 14 Apr 2015: New EurocanPlatform paper published in PLOS One 31 Mar 2015: Launch of personalised medicine survey: Literacy among healthcare professionals 30 Mar 2015: OECI Cancer Days 2015 in Porto, Portugal 10 Mar 2015: Workshop on circulating biomarkers in cancer 19 Feb 2015: Meeting report from the second EurocanPlatform summer school on translational cancer research published in ecancermedicalscience 27 Jan 2015: The January 2015 Newsletter is here! 21 Jan 2015: Most types of cancer not due to “bad luck”, says IARC 06 Jan 2015: Brand new videos available from the 2nd Translational Research Course 08 Dec 2014: New conference report for the EurocanPlatform Chemoprevention Meeting published in ecancermedicalscience 20 Nov 2014: The November 2014 Newsletter is here! 13 Nov 2014: IARC/WHO Fellowships 05 Nov 2014: Research course on circulating tumor cells (CTC) at the Karolinska Institute 28 Oct 2014: Eighth Belgian Symposium on the Integration of Molecular Biology Advances into Oncology Clinical Practice 01 Sep 2014: EurocanPlatform paper published in the Journal of Oncology Practice 18 Aug 2014: 4th Annual meeting of EurocanPlatform project, October 25-26th 2014 04 Aug 2014: EurocanPlatform Translational Cancer Research Summer Course, Portugal, October 20-24, 2014 31 Jul 2014: The Summer 2014 Newsletter is here! 18 Jun 2014: Role for an experienced scientist available at the Curie Institute 20 May 2014: New science policy paper published in Molecular Oncology 19 Feb 2014: Workshop on "Tissue-based Biomarkers for Advancement of Personalized Cancer Treatment" 21 Jan 2014: The second Advanced Lecture Course on Translational Cancer Research 21 Jan 2014: OECI and ECPC - How Uniform Is Cancer Care? February 18th 2014 31 Oct 2013: FDA pulls ponatinib approval due to blood clots and narrowing of blood vessels 22 Oct 2013: Publications from within EurocanPlatform - Year 2 09 Oct 2013: IARC: Postdoctoral fellowships for training in cancer research 12 Sep 2013: VHIO-Fritz Bender Foundation joint International Symposium 13 Aug 2013: HPV vaccine could also prevent oropharyngeal cancer, says IARC 13 Aug 2013: New ECPC Board of Directors 11 Jun 2013: EAPM Members Update: Discussion on the Data Protection Legislation 21 May 2013: Growing call to abandon impact factors 29 Apr 2013: New partnership between IARC and CRI to spur cancer research in Thailand and across South-East Asia 11 Apr 2013: OECI 2013 Oncology Days - including EurocanPlatform Session 08 Mar 2013: Spreading the cancer prevention message in Sierra Leone 25 Feb 2013: EAPM: Access to health data is essential for the development of new treatments 20 Feb 2013: Access to health data is essential for the development of new treatments, says European Alliance of Personalised Medicine 23 Jan 2013: Course in cancer genomics at EBI 26 Oct 2012: Scientists discover potential new 'roots' of breast cancer 19 Sep 2012: Personalised medicine promises radical improvements to healthcare in Europe